Wolfe Research began coverage on shares of Bruker (NASDAQ:BRKR – Free Report) in a research report report published on Wednesday, Marketbeat reports. The firm issued an outperform rating and a $80.00 target price on the medical research company’s stock. BRKR has been the subject of a number of other research reports. StockNews.com assumed coverage on […]